NPI: 1427143734 · WEST COVINA, CA 91790 · Obstetrics & Gynecology Physician · NPI assigned 10/03/2006
Authorized official FELDKAMP IV, IRVING controls 20+ related entities in our dataset. Read more
| Authorized Official | FELDKAMP IV, IRVING (OWNER) |
| NPI Enumeration Date | 10/03/2006 |
Other providers sharing the same authorized official: FELDKAMP IV, IRVING
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,872 | $421K |
| 2019 | 3,174 | $248K |
| 2020 | 2,927 | $109K |
| 2021 | 3,284 | $120K |
| 2022 | 3,913 | $153K |
| 2023 | 5,877 | $254K |
| 2024 | 5,293 | $173K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7,119 | 6,499 | $393K |
| J3490 | Unclassified drugs | 4,254 | 3,869 | $193K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 204 | 184 | $163K |
| A4267 | Contraceptive supply, condom, male, each | 5,836 | 5,786 | $100K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 302 | 298 | $92K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 722 | 710 | $70K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 78 | 55 | $64K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,302 | 1,291 | $56K |
| S4993 | Contraceptive pills for birth control | 370 | 367 | $55K |
| 58300 | 575 | 292 | $51K | |
| 11981 | 255 | 255 | $47K | |
| G9920 | Screening performed and negative | 928 | 926 | $27K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 492 | 389 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,299 | 1,288 | $20K |
| 90651 | 75 | 75 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 142 | 127 | $12K |
| 99000 | 847 | 843 | $12K | |
| 85018 | 120 | 117 | $10K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 14 | 14 | $9K |
| 87806 | 468 | 467 | $9K | |
| 76830 | Ultrasound, transvaginal | 156 | 153 | $8K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 486 | 486 | $6K |
| 81025 | 1,374 | 1,266 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 281 | 276 | $5K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 175 | 171 | $5K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 105 | 105 | $4K |
| 58301 | 143 | 75 | $3K | |
| S0190 | Mifepristone, oral, 200 mg | 82 | 82 | $3K |
| 87481 | 78 | 77 | $3K | |
| 11976 | 47 | 24 | $3K | |
| 99201 | 16 | 16 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 68 | 68 | $2K |
| 87799 | 66 | 65 | $2K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 283 | 278 | $1K |
| 87563 | 38 | 38 | $1K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 366 | 351 | $415.14 |
| 86592 | 12 | 12 | $346.79 | |
| S0191 | Misoprostol, oral, 200 mcg | 123 | 123 | $207.18 |
| 83986 | 39 | 39 | $115.39 |